Jul 12, 2017 09:30:00 (ET)
PRESCRIPTIONS ON LIEN FOR PERSONAL INJURY PATIENTS
LAS VEGAS, NV, July 12, 2017 (GLOBE NEWSWIRE) --
Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that its wholly owned subsidiary pharmacy, Nevada Health Rx, Inc. ("NHRX"), located in Las Vegas, Nevada, is taking prescriptions on lien with home delivery for personal injury patients.
NHRX accepts and will provide prescriptions for people injured in a variety of ways with clear liability, including auto accidents, slip and fall injuries and dog bite cases which are just to name a few types of injuries in which NHRX will provide medications to patients on lien. Our home delivery and competitive pricing provides a valued service to the patient while they recover from their traumatic and often debilitating experience.
Praxsyn's Chief Executive Officer, Greg Sundem, commented, "personal injury claims can be a very secure and lucrative market for our pharmacy division, and we have established internal systems to manage the collection process to ensure a profitable business line. I am pleased to be expanding our business in Nevada with additional licensing in other strategic markets".
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation through its wholly owned subsidiaries Mesa Pharmacy and Nevada Health Rx, work to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding prescriptions on lien for personal injury patients, and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
###
Media/Investor Contact:
IR@PraXsyn.com
949-777-6112 ext. 101
(END) Dow Jones Newswires
July 12, 2017 09:30 ET (13:30 GMT)
